As the studies with SPC-Flakes® showed, there are some patients that are non-responders when treated with AF inducing specially processed cereals (SPC-Flakes®). Due to the positive results of Salovum®in the treatment of secretory diarrhoea, it was tested on Ménière’s disease as well.
AF-inducing SPC-Flakes® was tested during a two month period on a 67 year old woman with a thirty year history of Ménière’s disease. She had frequent attacks lasting for 8 hours up to three days with nausea, vertigo, diarrhoea and vomiting. When the SPC-Flakes ®diet did not improve neither the duration of the attacks nor the severity, she was given Salovum® at a dose of 2 g five times daily to see if this exogenous administration of AF in high concentrations could offer positive clinical results.
On day 18 of the treatment the patient was completely relieved of her symptoms and her Ménière status was improved from 6 to 1 (American Academy of Otolaryngology). After six months of symptomatic relief the patient lowered the dosage of Salovum® with the result that her attacks with rotatory vertigo returned. Returning to the original dosage level led to immediate improvement without the need for further medication. No improvement, however, could be seen on her right-sided hearing impairment.
The results show that patients who do not respond to treatment with AF-inducing cereals can be favourably treated with Salovum®. To stimulate the body’s own production of AF it is of value that an introduction of AF-inducing cereals is made in connection with or as a follow-up to Salovum® treatment.
Hanner, Jennische and Lange, Antisecretory Factor: A clinical innovation in Ménière’s disease?, Acta Otolaryngol, 2003; 123:779-780, view link